Related Experiment Video

Updated: Jul 5, 2026

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice
07:41

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice

Published on: June 8, 2022

Mitochondrial respiratory dysfunction in familiar parkinsonism associated with PINK1 mutation

Claudia Piccoli1, Annamaria Sardanelli, Rosella Scrima

  • 1Department of Biomedical Sciences, University of Foggia, Foggia, Italy.

Neurochemical Research
|May 14, 2008
PubMed

Insights

Early-onset parkinsonism linked to PINK1 mutations impairs mitochondrial function. Fibroblasts show reduced respiration and increased oxidative stress, impacting cellular energy production.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Neuroscience

Background:

  • Mitochondrial dysfunction is implicated in Parkinson's disease.
  • Mutations in the PINK1 gene are associated with early-onset parkinsonism.
  • Fibroblasts offer a model to study cellular defects in neurological disorders.

Observation:

  • Patient fibroblasts with PINK1 W437X mutation exhibit reduced mitochondrial respiratory activity.
  • Cellular ATP supply is compensated by increased glycolysis.
  • Cytochrome c levels and activity are decreased, correlating with reduced Complex IV function.

Findings:

  • Mitochondrial oxidative phosphorylation complex quantity and activity are normal.
  • Enhanced production of reactive oxygen species (ROS), specifically superoxide and hydrogen peroxide, was observed.
  • ROS production is linked to Complex I activity.

Implications:

  • This study elucidates specific mitochondrial defects in PINK1-related parkinsonism.
  • Findings suggest a role for impaired electron transport chain function and oxidative stress in disease pathogenesis.
  • Targeting mitochondrial dysfunction and oxidative stress may offer therapeutic strategies for early-onset parkinsonism.

More Related Videos

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Analyzing Mitochondrial Function in a Drosophila melanogaster PINK1B9-Null Mutant Using High-resolution Respirometry09:20

Analyzing Mitochondrial Function in a Drosophila melanogaster PINK1B9-Null Mutant Using High-resolution Respirometry

Published on: November 10, 2023

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...